Developer docs
API playgroundTry for free, no card

Search company profiles

Chalver Laboratories

Full company profile

uuid002a5fg

Namestring
Chalver Laboratories
Legal namestring
Laboratorios Chalver de Colombia S.A.S.
Websiteurl
chalver.com
Company typeenum
Private
Founded yearint
1970
Descriptiontext

Chalver Laboratories (legal name Laboratorios Chalver de Colombia S.A.S.) is a privately held Colombian pharmaceutical manufacturer founded in 1970 and headquartered in Bogotá. The company develops, manufactures, and commercializes branded generic medications for human and veterinary use across four product lines: Primary Care, Institutional/Hospital, OTC, and Veterinary. Its 20,000 square meter production plant in Bogotá is INVIMA-certified (BPM/Good Manufacturing Practices) and was selected as a model plant for an OPS (Pan American Health Organization) inspection; the plant operates automated high-volume equipment with batch capacities up to 5,600 liters for liquids and 1,200 kg for solids, and includes the only facilities in Colombia specialized in metered-dose inhaler manufacturing and hormonal medication production.

The company monetizes through two principal channels: (1) direct sales of its branded pharmaceutical portfolio (including Multidol®, Fluturan®, Tibonella®, Estermax®, Inlabon®, Airmax®, and others spanning analgesics, women's health, respiratory, dermatology, ophthalmology, and intrahospital therapeutics) via its own field sales force and through major regional pharmacy chains, and (2) maquila contract manufacturing services for hormonal, veterinary, and human-use pharmaceutical products, plus lithographic printing and pharmacovigilance services as adjacent revenue streams.

Chalver operates wholly-owned administrative subsidiaries with direct sales infrastructure in 8 countries across South America, Central America, and the Caribbean (Colombia, Ecuador, El Salvador, Honduras, Panama, Dominican Republic, Nicaragua, Guatemala, and Aruba/Curacao), promoting its portfolio to more than 10 medical specialties in both private and institutional channels. No public listing, parent company, or external funding is disclosed; the company is privately held with no venture capital or private equity investment identified in the source material.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBogotá, Colombia
HQ citystring
Bogotá
HQ countrystring
Colombia
HQ regionstring
Latin America
Markets served

Serves global market

Offices11 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, human medications, veterinary pharmaceuticals, contract manufacturing services, metered-dose inhalers
Industry1 code
PRIMARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Product Sales
TypeOne Time License
Description

Development, manufacturing, and commercialization of human and veterinary pharmaceutical products including OTC, institutional, primary care, and specialty medications. Products are promoted to more than 10 medical specialties through direct sales force.

chalver.com
2Contract Manufacturing (Maquila) Services
TypeProfessional Services
Description

Provides contract manufacturing services for hormonal products, veterinary products, and human-use products. Services include formulation, packaging, and quality control for third-party clients.

chalver.com
3Lithography and Printing Services
TypeProfessional Services
Description

Provides lithographic printing services including sheet and quarter-sheet formats (6, 4, and 2 colors), die-cutting, automatic gluing, laminating, CTP plate making, digital printing, flexography, and special finishes.

chalver.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Hormonal Products Manufacturing
Description

The only plant in Colombia for the development and manufacture of hormonal medications for human use, including contraceptives and menopause treatments

chalver.com
+2 more records
Core offering1 text field

Laboratorios Chalver de Colombia S.A.S. develops, manufactures, and commercializes human and veterinary pharmaceutical products across primary care, institutional, OTC, and specialty lines, operating a 20,000 sqm INVIMA-certified production plant in Bogotá. In parallel, the company offers contract manufacturing (maquila) services for hormonal, veterinary, and human-use pharmaceuticals, plus lithographic printing services, distributing its branded portfolio across 8 Latin American and Caribbean countries through its own field sales force and retail pharmacy chains.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Chalver Laboratories is a Colombian pharmaceutical company with 53 years of experience manufacturing and commercializing human and veterinary medications. The company operates a 20,000 square meter production plant in Bogotá and offers a diversified portfolio organized into therapeutic categories: OTC health products (analgesics, cold/flu, probiotics), Women's Health (hormone replacement, vaginal treatments), Neuromuscular & Joint Health (B-complex vitamins, corticosteroids, anti-inflammatories), Digestive Health (laxatives, antiparasitics), Respiratory Health (inhalers for asthma/COPD), Skin Health (topical corticosteroids, antifungals), Eye Health (antibiotic/anti-inflammatory ophthalmic solutions), and Intrahospital Products (hormonal injections, anticoagulants, sedatives). Beyond its branded pharmaceutical portfolio, Chalver provides contract manufacturing services (maquila) for hormonal products, veterinary products, and human-use pharmaceuticals, plus lithographic printing services. The company operates across 8 countries in South America, Central America, and the Caribbean with headquarters in Bogotá, Colombia.

Product and service1 record
1Multidol®
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

South African-headquartered specialty pharmaceutical company with international manufacturing and distribution across emerging markets. Comparable to Chalver as an emerging-market pharma operator with contract manufacturing capabilities and focus on women's health and specialty categories.

TypeEmerging player
Description

India-based pharmaceutical manufacturer with growing Latin American presence in dermatology, respiratory, and women's health. Comparable as an emerging-market manufacturer competing with Chalver in similar therapeutic categories and regional markets.

3Lafrancol
TypeDirect peer
Description

Colombian pharmaceutical laboratory operating across multiple therapeutic categories with a Latin American commercial footprint. Directly comparable to Chalver as a fellow Colombian pharma manufacturer competing in the same retail and institutional channels.

TypeDirect peer
Description

Colombian pharmaceutical laboratory with broad therapeutic categories and Latin American presence. Directly comparable to Chalver in product mix, Colombian origin, and multi-country distribution.

5Procaps
TypeDirect peer
Description

Colombian pharmaceutical company with softgel and sterile manufacturing capabilities and Latin American distribution. Comparable to Chalver in pharma contract manufacturing (maquila), softgel expertise, and regional go-to-market model.

TypeDirect peer
Description

Colombian-affiliated generic and branded pharmaceutical manufacturer with regional Latin American distribution. Comparable to Chalver in therapeutic breadth, OTC/generic positioning, and multi-country presence in the Andean and Central American markets.

TypeDirect peer
Description

Colombian pharmaceutical manufacturer with a similar multi-country Latin American footprint and broad therapeutic portfolio spanning OTC, prescription, and institutional products. Directly comparable in terms of being a regionally diversified Colombian pharma brand competing in primary care and institutional channels.

TypeBroad incumbent
Description

Global pharmaceutical incumbent with established Latin American commercial operations across OTC, women's health, and respiratory categories. Comparable as a broad incumbent competing with Chalver in therapeutic areas like hormone therapy and OTC analgesics.

9Eurofarma
TypeBroad incumbent
Description

Brazilian-headquartered multinational pharmaceutical company with the broadest Latin American footprint. Comparable as a larger incumbent regional pharma competitor that overlaps with Chalver in OTC, prescription, and contract manufacturing across Latin American markets.

TypeRegional player
Description

Uruguay-headquartered pharmaceutical company with strong Latin American presence across multiple therapeutic areas. Comparable to Chalver as a Latin American regional pharma player with overlapping product portfolio and similar go-to-market strategy in primary care and OTC.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Chalver Laboratories

Pharmaceutical Manufacturingchalver.com

What Chalver Laboratories does

Chalver Laboratories (legal name Laboratorios Chalver de Colombia S.A.S.) is a privately held Colombian pharmaceutical manufacturer founded in 1970 and headquartered in Bogotá. The company develops, manufactures, and commercializes branded generic medications for human and veterinary use across four product lines: Primary Care, Institutional/Hospital, OTC, and Veterinary. Its 20,000 square meter production plant in Bogotá is INVIMA-certified (BPM/Good Manufacturing Practices) and was selected as a model plant for an OPS (Pan American Health Organization) inspection; the plant operates automated high-volume equipment with batch capacities up to 5,600 liters for liquids and 1,200 kg for solids, and includes the only facilities in Colombia specialized in metered-dose inhaler manufacturing and hormonal medication production.

The company monetizes through two principal channels: (1) direct sales of its branded pharmaceutical portfolio (including Multidol®, Fluturan®, Tibonella®, Estermax®, Inlabon®, Airmax®, and others spanning analgesics, women's health, respiratory, dermatology, ophthalmology, and intrahospital therapeutics) via its own field sales force and through major regional pharmacy chains, and (2) maquila contract manufacturing services for hormonal, veterinary, and human-use pharmaceutical products, plus lithographic printing and pharmacovigilance services as adjacent revenue streams.

Chalver operates wholly-owned administrative subsidiaries with direct sales infrastructure in 8 countries across South America, Central America, and the Caribbean (Colombia, Ecuador, El Salvador, Honduras, Panama, Dominican Republic, Nicaragua, Guatemala, and Aruba/Curacao), promoting its portfolio to more than 10 medical specialties in both private and institutional channels. No public listing, parent company, or external funding is disclosed; the company is privately held with no venture capital or private equity investment identified in the source material.

Chalver Laboratories firmographics

Firmographics
Name
Chalver Laboratories
Legal name
Laboratorios Chalver de Colombia S.A.S.
Website
https://chalver.com
Company type
Private
Founded year
1970
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Chalver Laboratories industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services

Keywords

  • Pharmaceutical manufacturing
  • Human medications
  • Veterinary pharmaceuticals
  • Contract manufacturing services
  • Metered-dose inhalers

Where Chalver Laboratories is headquartered

Location

Headquarters

HQ city
Bogotá
HQ country
Colombia
HQ region
Latin America

Offices11 records

Markets served

Chalver Laboratories business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: Development, manufacturing, and commercialization of human and veterinary pharmaceutical products including OTC, institutional, primary care, and specialty medications. Products are promoted to more than 10 medical specialties through direct sales force.
  2. Contract Manufacturing (Maquila) Services: Provides contract manufacturing services for hormonal products, veterinary products, and human-use products. Services include formulation, packaging, and quality control for third-party clients.
  3. Lithography and Printing Services: Provides lithographic printing services including sheet and quarter-sheet formats (6, 4, and 2 colors), die-cutting, automatic gluing, laminating, CTP plate making, digital printing, flexography, and special finishes.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Chalver Laboratories product offering

Product offering

Core offering

Laboratorios Chalver de Colombia S.A.S. develops, manufactures, and commercializes human and veterinary pharmaceutical products across primary care, institutional, OTC, and specialty lines, operating a 20,000 sqm INVIMA-certified production plant in Bogotá. In parallel, the company offers contract manufacturing (maquila) services for hormonal, veterinary, and human-use pharmaceuticals, plus lithographic printing services, distributing its branded portfolio across 8 Latin American and Caribbean countries through its own field sales force and retail pharmacy chains.

Product overview

Chalver Laboratories is a Colombian pharmaceutical company with 53 years of experience manufacturing and commercializing human and veterinary medications. The company operates a 20,000 square meter production plant in Bogotá and offers a diversified portfolio organized into therapeutic categories: OTC health products (analgesics, cold/flu, probiotics), Women's Health (hormone replacement, vaginal treatments), Neuromuscular & Joint Health (B-complex vitamins, corticosteroids, anti-inflammatories), Digestive Health (laxatives, antiparasitics), Respiratory Health (inhalers for asthma/COPD), Skin Health (topical corticosteroids, antifungals), Eye Health (antibiotic/anti-inflammatory ophthalmic solutions), and Intrahospital Products (hormonal injections, anticoagulants, sedatives). Beyond its branded pharmaceutical portfolio, Chalver provides contract manufacturing services (maquila) for hormonal products, veterinary products, and human-use pharmaceuticals, plus lithographic printing services. The company operates across 8 countries in South America, Central America, and the Caribbean with headquarters in Bogotá, Colombia.

Differentiator

Problem solved

Functional benefit

Brands

  • Hormonal Products Manufacturing: The only plant in Colombia for the development and manufacture of hormonal medications for human use, including contraceptives and menopause treatments
  • Litography Services
  • Veterinary Products Manufacturing

Products and services

  • Multidol®

Companies that use Chalver Laboratories

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Chalver Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Chalver Laboratories partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Chalver Laboratories competitors and assessment

Company assessment

Emerging players

  • Aspen Pharmacare: South African-headquartered specialty pharmaceutical company with international manufacturing and distribution across emerging markets. Comparable to Chalver as an emerging-market pharma operator with contract manufacturing capabilities and focus on women's health and specialty categories.
  • Glenmark Pharmaceuticals: India-based pharmaceutical manufacturer with growing Latin American presence in dermatology, respiratory, and women's health. Comparable as an emerging-market manufacturer competing with Chalver in similar therapeutic categories and regional markets.

Direct peers

  • Lafrancol: Colombian pharmaceutical laboratory operating across multiple therapeutic categories with a Latin American commercial footprint. Directly comparable to Chalver as a fellow Colombian pharma manufacturer competing in the same retail and institutional channels.
  • Cifarma: Colombian pharmaceutical laboratory with broad therapeutic categories and Latin American presence. Directly comparable to Chalver in product mix, Colombian origin, and multi-country distribution.
  • Procaps: Colombian pharmaceutical company with softgel and sterile manufacturing capabilities and Latin American distribution. Comparable to Chalver in pharma contract manufacturing (maquila), softgel expertise, and regional go-to-market model.
  • Genfar: Colombian-affiliated generic and branded pharmaceutical manufacturer with regional Latin American distribution. Comparable to Chalver in therapeutic breadth, OTC/generic positioning, and multi-country presence in the Andean and Central American markets.
  • Tecnoquímicas: Colombian pharmaceutical manufacturer with a similar multi-country Latin American footprint and broad therapeutic portfolio spanning OTC, prescription, and institutional products. Directly comparable in terms of being a regionally diversified Colombian pharma brand competing in primary care and institutional channels.

Broad incumbents

  • Bayer: Global pharmaceutical incumbent with established Latin American commercial operations across OTC, women's health, and respiratory categories. Comparable as a broad incumbent competing with Chalver in therapeutic areas like hormone therapy and OTC analgesics.
  • Eurofarma: Brazilian-headquartered multinational pharmaceutical company with the broadest Latin American footprint. Comparable as a larger incumbent regional pharma competitor that overlaps with Chalver in OTC, prescription, and contract manufacturing across Latin American markets.

Regional players

  • Megalabs: Uruguay-headquartered pharmaceutical company with strong Latin American presence across multiple therapeutic areas. Comparable to Chalver as a Latin American regional pharma player with overlapping product portfolio and similar go-to-market strategy in primary care and OTC.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Chalver Laboratories social profiles

Digital presence

Chalver Laboratories compliance and trust

Trust signal

Compliance1 record

Chalver Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Chalver Laboratories leadership team

Management profile

Number of profiles

Chalver Laboratories subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

Chalver Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Chalver Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chalver Laboratories

What does Chalver Laboratories do?

Laboratorios Chalver de Colombia S.A.S. develops, manufactures, and commercializes human and veterinary pharmaceutical products across primary care, institutional, OTC, and specialty lines, operating a 20,000 sqm INVIMA-certified production plant in Bogotá. In parallel, the company offers contract manufacturing (maquila) services for hormonal, veterinary, and human-use pharmaceuticals, plus lithographic printing services, distributing its branded portfolio across 8 Latin American and Caribbean countries through its own field sales force and retail pharmacy chains.

Is Chalver Laboratories a public or private company?

Chalver Laboratories is a private company. It is classified as unknown and is currently operating.

When was Chalver Laboratories founded?

Chalver Laboratories was founded in 1970. It employs 11 to 50 people.

Where is Chalver Laboratories based?

Chalver Laboratories is headquartered in Bogotá, Colombia, in the Latin America region.

How does Chalver Laboratories make money?

Three revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are contract Manufacturing (Maquila) Services and lithography and Printing Services.

Who are Chalver Laboratories's main competitors?

Emerging players on record are Aspen Pharmacare and Glenmark Pharmaceuticals. Direct peers are Lafrancol, Cifarma, Procaps, Genfar and Tecnoquímicas. Broad incumbents are Bayer and Eurofarma. Megalabs is listed as a regional player.

Does Chalver Laboratories have an API?

No public API is recorded for Chalver Laboratories.

What industry is Chalver Laboratories in?

Chalver Laboratories's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAAAKAB, Drug Product Fill-Finish & Aseptic Manufacturing Services. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales